Press "Enter" to skip to content

Latest situation in domestic corona virus vaccine: ‘Phase-2 will be completed in mid-April’ – Health News


Kayseri Erciyes University within the Vaccine Research and Development Center (ERAG I) and Good Clinical Practice and Research Center (IC I) by corona developed and the Ministry of Health against the virus Turkey Institutes of Health Administration (TÜSEB) is supported by Covidien-19 domestic vaccine Phase 1 study 44 It was done on volunteers and was completed as of December 14th.

PHASE-2 STUDIES STARTED IN FEBRUARY

Phase-2 studies of the inactive vaccine started in February. Within the scope of Phase-2, the first dose of the vaccine was administered to 250 volunteers. Second dose vaccinations in Phase-2 continue to be administered to the same volunteers.

“ 50 PEOPLE COMPLETED IN THE SECOND Dose ”

IKUM Director Assoc. Dr. Zafer Sezer, Stating that 250 volunteers were vaccinated during the phase-2 phase, he said, “Everything we will do in the clinical phase is under the protocol. Everything we will do there is written. We determined 250 people in our planning. We have completed 50 people in vaccination. Every day, our volunteers are vaccinated for a certain period. Some side effects were seen in our vaccine, but these effects are not serious side effects. and headaches are also seen. This did not happen to everyone in general, of course, “he said.

” WE WILL FINISH PHASE-2 STUDY IN THE MIDDLE OF APRIL ”

Assoc. Dr. Sezer said, “We will finish the Phase-2 study in mid-April. Because there will be laboratory studies and the evaluation and analysis of the available data will be carried out. There will be an evaluation until the end of April. Many studies are carried out on the Phase 3 study. These studies are carried out by the Ministry of Health and TÜSEB.” he spoke.

Sezer warns the citizens, “It is important to follow the ministry’s warnings even if you are vaccinated. Even if you are not sick yourself after the vaccination, there may be contagiousness. Even the vaccines currently in use, clinical research continues. At least 1-year follow-up is required. Data on protection and infectiousness emerges over time.

VIDEO: IMPORTANT STEP FOR DOMESTIC VACCINE

Download the NTV application, be informed about the developments


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *